✦ LIBER ✦
5001 ORAL Trastuzumab Emtansine (T-DM1) Vs Trastuzumab Plus Docetaxel (H+T) in Previously-untreated HER2-positive Metastatic Breast Cancer (MBC): Primary Results of a Randomized, Multicenter, Open-label Phase II Study (TDM4450g/BO21976)
✍ Scribed by Hurvitz, S.; Dirix, L.; Kocsis, J.; Gianni, L.; Lu, J.; Vinholes, J.; Song, C.; Tong, B.; Chu, Y.W.; Perez, E.A.
- Book ID
- 122623362
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 42 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.